Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 525,321 | 499,672 | 573,839 | 498,697 | 510,422 |
| Cost of Goods | 225,220 | 228,260 | 258,933 | 224,927 | 222,522 |
| Gross Profit | 300,101 | 271,412 | 314,906 | 273,770 | 287,900 |
| Operating Expenses | 247,392 | 236,520 | 245,178 | 208,856 | 215,114 |
| Operating Income | 52,929 | 35,152 | 70,661 | 65,841 | 73,308 |
| Interest Expense | 11,664 | 10,977 | 13,614 | 11,901 | 12,401 |
| Other Income | 7,779 | -128 | 5,659 | 1,063 | 5,112 |
| Pre-tax Income | 49,044 | 24,047 | 62,706 | 55,003 | 66,019 |
| Income Tax | 14,442 | 3,875 | 19,289 | 12,383 | 17,454 |
| Net Income Continuous | 34,602 | 20,172 | 43,417 | 42,620 | 48,565 |
| Minority Interests | N/A | 21 | -79 | -13 | 222 |
| Net Income | $34,602 | $20,151 | $43,496 | $42,633 | $48,343 |
| EPS Basic Total Ops | 1.21 | 0.71 | 1.53 | 1.51 | 1.71 |
| EPS Basic Continuous Ops | 1.21 | 0.71 | 1.53 | 1.51 | 1.72 |
| EPS Diluted Total Ops | 1.20 | 0.70 | 1.51 | 1.49 | 1.69 |
| EPS Diluted Continuous Ops | 1.20 | 0.70 | 1.51 | 1.49 | 1.70 |
| EBITDA(a) | $52,929 | $35,152 | $70,661 | $65,841 | $73,308 |